GenomSys is pleased to introduce the new Board that was appointed on July 09th 2024 in Lugano. Dr. Ing. Antonio Aitoro, CEO, Dr. Matteo Colafrancesco, Secretary, and Dr. Luisa Graziani, President & Chairman.
On behalf of the whole of shareholders, GenomSys wants to thank Luisa Graziani, who is the CEO of the lead investor ROMED SPA, for her strong and increasing commitment in the Company and for her continuous energetic support.
We are proud to have a successful woman at the helm and we’ll continue to boost our presence in the healthcare SW arena leveraging the MPEG-G ISO/IEC 23092 genomic international standard and our integrated platform. Stay tuned.
